tiprankstipranks
Advertisement
Advertisement
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
PremiumThe FlyNanoViricides reports Q1 EPS (9c) vs. (14c) last year
16d ago
NanoViricides says hantavirus incident highlights need for antiviral drugs
Premium
The Fly
NanoViricides says hantavirus incident highlights need for antiviral drugs
20d ago
NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
Premium
The Fly
NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
27d ago
NanoViricides completes manufacture of NV-387 oral gummies
PremiumThe FlyNanoViricides completes manufacture of NV-387 oral gummies
3M ago
NanoViricides files application for orphan drug designation for NV-387
Premium
The Fly
NanoViricides files application for orphan drug designation for NV-387
4M ago
NanoViricides files application for orphan drug designation for NV-387
Premium
The Fly
NanoViricides files application for orphan drug designation for NV-387
4M ago
NanoViricides Holds 2025 Annual Stockholders Meeting
PremiumCompany AnnouncementsNanoViricides Holds 2025 Annual Stockholders Meeting
6M ago
NanoViricides reports Q3 EPS (10c) vs. (23c) last year
Premium
The Fly
NanoViricides reports Q3 EPS (10c) vs. (23c) last year
6M ago
NanoViricides Secures $6 Million Through Securities Offering
Premium
Company Announcements
NanoViricides Secures $6 Million Through Securities Offering
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100